News and Announcements
Al Mana Entertainment in Qatar orders 4th Pacific Simulator in 12 months
- Published November 13, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
After taking delivery of three single seat simulators earlier this year, the diversified Qatari trading group, Al Mana, has ordered another Boeing 737 flight simulator from New Zealand-based Pacific Simulators (Pacsim), which will operate as Flight Experience Doha from one of Al Mana’s many entertainment venues.
Al Mana Entertainment General Manager, John Becker was pleased in awarding the contract to Pacsim. “We have had a long association with Pacific Simulators and we are excited to finally be opening the first Flight Experience in Doha. We are planning to establish the outlet in the new Mirqab Mall near the centre of Doha. The simulator will compliment our other outstanding entertainment products, but provide a unique and exciting opportunity for anyone to experience flying a Boeing 737”.
The ProJet PS4.5 flight simulator is Pacsim’s top of the range model, priced at over NZ$600,000. The device is built using actual Boeing 737 aircraft parts that have been refurbished from decommissioned aircraft out of the US. The level of fidelity and accuracy to the real aircraft is very high, with the software and visual systems creating the sense of being in the real aircraft. The simulator will be delivered in Q2 2018 and operational be the middle of the year. The simulator will be the only one of its type in Qatar.
About Pacific Simulators 2010 Ltd
Pacific Simulators (Pacsim) is a flight simulator manufacturer who have designed and built cost-effective training simulators suitable for airlines.
The airline industry is booming with over 12,000 Boeing and Airbus planes on order and a demand for nearly 700,000 pilots over the next 20 years.
Pacsim have created the perfect simulator solution to enable cost-effective training with better training outcomes for airlines with Boeing 737 and Airbus A320 aircraft.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
